Abstract B38: Increasing tumor-infiltrating CD8+ T cell response and checkpoint inhibitor efficacy by enzymatic reduction of tumor hyaluronan in a murine syngeneic pancreatic cancer model | Citedby Results | Cancer Immunology Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract B38: Increasing tumor-infiltrating CD8+ T cell response and checkpoint inhibitor efficacy by enzymatic reduction of tumor hyaluronan in a murine syngeneic pancreatic cancer model

Cancer Immunol Res (2018) 6 (9_Supplement): B38.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment

Neha Parayath
Smrithi Padmakumar
Shantikumar V. Nair
Deepthy Menon
Mansoor M. Amiji

Regenerative Engineering and Translational Medicine (2020) 6 (1): 29.

Degradation of tumour stromal hyaluronan by small extracellular vesicle‐PH20 stimulates CD103+ dendritic cells and in combination with PD‐L1 blockade boosts anti‐tumour immunity

Yeonsun Hong
Yoon Kyoung Kim
Gi Beom Kim
Gi‐Hoon Nam
Seong A Kim
Yoon Park
Yoosoo Yang
In‐San Kim

Journal of Extracellular Vesicles (2019) 8 (1)